Clinicopathological characterization of duodenal adenocarcinoma with high CD44 variant 9 expression
暂无分享,去创建一个
[1] J. Troelsen,et al. Clinical implications of intestinal stem cell markers in colorectal cancer. , 2015, Clinical colorectal cancer.
[2] M. Sugiyama,et al. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[3] M. Kasahara,et al. Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis. , 2015, Experimental and molecular pathology.
[4] M. Fukayama,et al. Extra-ampullary Duodenal Adenocarcinoma , 2014, The American journal of surgical pathology.
[5] M. Lisanti,et al. Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer , 2014, Oncotarget.
[6] S. Okazaki,et al. Redox regulation in stem-like cancer cells by CD44 variant isoforms , 2013, Oncogene.
[7] N. Ashley,et al. Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. , 2013, Cancer research.
[8] F. Gao,et al. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. , 2013, Gene.
[9] T. Hibi,et al. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence , 2013, British Journal of Cancer.
[10] T. Urano,et al. CD44variant exon 9 plays an important role in colon cancer initiating cells , 2013, Oncotarget.
[11] B. Aggarwal,et al. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. , 2012, Antioxidants & redox signaling.
[12] J. Ji,et al. Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] Kun Yang,et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients , 2011, Cell Research.
[14] Hans Clevers,et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.
[15] M. Ohmura,et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.
[16] L. Bourguignon,et al. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. , 2011, The American journal of pathology.
[17] L. Terracciano,et al. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer , 2010, British Journal of Cancer.
[18] Hans Clevers,et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. , 2009, Gastroenterology.
[19] D. K. Lorance,et al. Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[20] S. Islam,et al. Attributes of adult stem cells , 2009, The Journal of pathology.
[21] P. Carter,et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers , 2008, British Journal of Cancer.
[22] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[23] K. Konstantopoulos,et al. Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells , 2006, Journal of Biological Chemistry.
[24] H. Li,et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2006, Oncogene.
[25] N. Maitland,et al. Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.
[26] H. Okano,et al. Function of RNA-binding protein Musashi-1 in stem cells. , 2005, Experimental cell research.
[27] H. Saya,et al. Mechanism and biological significance of CD44 cleavage , 2004, Cancer science.
[28] Y. Guan,et al. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). , 2003, Blood.
[29] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[31] M. Fujita,et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. , 2000, Oral oncology.
[32] J. Donohue,et al. What prognostic factors are important in duodenal adenocarcinoma? , 2000, Archives of surgery.
[33] L. Karnell,et al. Adenocarcinoma of the small bowel , 1999 .
[34] C. Eaves,et al. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. , 1999, Blood.
[35] J. Fujimoto,et al. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression. , 1998, International journal of oncology.
[36] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[37] Robert E. Brown,et al. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. , 2011, International journal of clinical and experimental pathology.
[38] M. Clarke,et al. Identification of pancreatic cancer stem cells. , 2007, Cancer research.